FDA Adverse Event Other Summary report: N

OVATION PRIME ABDOMINAL STENT GRAFT SYSTEM

MDR report key: 3783530 · Received April 15, 2014

Report

Report Number
3008011247-2014-00019
Event Type
Other
Date Received
April 15, 2014
Date of Event
April 28, 2014
Report Date
May 19, 2014
Manufacturer
TRIVASCULAR, INC.
Product Code
MIH
PMA / PMN Number
P120006
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
HU
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE PATIENT RETURNED FOR A FOLLOW-UP CT ON (B)(6) 2014. BASED ON A REVIEW COMPLETED BY TRIVASCULAR ON (B)(6) 2014, THE ENDOLEAK WAS DETERMINED TO BE A TYPE II ENDOLEAK AND NOT A TYPE IA. TYPE II ENDOLEAKS ARE NOT CONSIDERED TO BE RELATED TO THE DEVICE BUT RATHER RELATED TO THE ANATOMY. THERE HAVE BEEN NO ADVERSE PATIENT SEQUELAE REPORTED. REMAINS IMPLANTED.

Description of Event or Problem · 1

THE PT UNDERWENT ENDOVASCULAR REPAIR OF AAA WITH THE OVATION PRIME ABDOMINAL STENT GRAFT SYSTEM ON (B)(6) 2014. THE AORTIC BODY AND ILIAC LIMBS WERE DEPLOYED AS EXPECTED. UPON FINAL ANGIO, AN ENDOLEAK WAS OBSERVED NEAR THE PROXIMAL SEALING RINGS. THE PHYSICIAN COULD NOT DETERMINE IF THE ENDOLEAK WAS A TYPE IA OR A TYPE II. THE SEALING RINGS WERE BALLOONED WITH A COMPLIANT BALLOON AND THE ENDOLEAK DID NOT RESOLVE. THE PHYSICIAN ELECTED TO MONITOR THE ENDOLEAK AT A FOLLOW-UP PT VISIT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
230827 OVATION PRIME ABDOMINAL STENT GRAFT SYSTEM ENDOVASCULAR GRAFT, AORTIC ANEURYSM MIH TRIVASCULAR, INC. TV-AB2680-D FS111413-42

Patients

Seq Age Sex Outcome Treatment
1 69 YR Other